Comparative in vitro and in vivo evaluation of N-D-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B

N-D-Ornithyl amphotericin B methyl ester (O-AME), a semisynthetic derivative of amphotericin B methyl ester (AME), was compared with amphotericin B (AMB) and AME. In vitro, O-AME was more active than the other two against Candida spp. and other fungi and was only slightly affected by inoculum size, addition of serum, or changes in pH. In vivo, the dose of O-AME required to produce a 10,000-fold reduction of Candida albicans in a mouse kidney infection was similar to that of AMB and 1/10 that of AME. After intravenous treatment of infected mice and rats and subcutaneous treatment of mice, average 50% protective doses for O-AME and AMB were similar. Acute intravenous 50% lethal doses in mice indicated that O-AME was one-ninth as toxic as AMB but twice as toxic as AME. Acute renal function tests in rats indicated that Sch 28191 was less than 1/10 as toxic as AMB and slightly more toxic than AME. On this basis, the calculated advantage relative to AMB (with AMB equal to 1) was 8 for O-AME and 1.5 for AME.

[1]  J. Perfect,et al.  Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis , 1985, Antimicrobial Agents and Chemotherapy.

[2]  R. Weglein,et al.  Subchronic toxicity studies of N-D-ornithyl amphotericin B methyl ester in dogs and rats. , 1985, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[3]  E. Brummer,et al.  Activities of the modified polyene N-D-ornithyl amphotericin methyl ester and the azoles ICI 153066, Bay n 7133, and Bay l 9139 compared with those of amphotericin B and ketoconazole in the therapy of experimental blastomycosis , 1985, Antimicrobial Agents and Chemotherapy.

[4]  G. Medoff,et al.  In vitro and in vivo comparisons of amphotericin B and N-D-ornithyl amphotericin B methyl ester , 1985, Antimicrobial Agents and Chemotherapy.

[5]  D. Loebenberg,et al.  Comparative pharmacokinetics of Sch 28191 and amphotericin B in mice, rats, dogs, and cynomolgus monkeys , 1984, Antimicrobial Agents and Chemotherapy.

[6]  J. Galgiani,et al.  Ornithyl amphotericin methyl ester treatment of experimental candidiasis in rats , 1984, Antimicrobial Agents and Chemotherapy.

[7]  R. Sobel,et al.  Leukoencephalopathy in patients treated with amphotericin B methyl ester. , 1982, The Journal of infectious diseases.

[8]  D. Loebenberg,et al.  N-aminoacyl derivatives of polyene macrolide antibiotics and their esters. , 1982, The Journal of antibiotics.

[9]  W. J. Martin,et al.  Comparative in vitro susceptibility of yeasts to amphotericin B and three methyl ester derivatives , 1981, Antimicrobial Agents and Chemotherapy.

[10]  P. Chiu,et al.  Renal Pharmacology of Netilmicin , 1977, Antimicrobial Agents and Chemotherapy.

[11]  C. Klepner,et al.  Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice. , 1976, The Journal of infectious diseases.

[12]  Y. Yoon,et al.  Comparative Toxicological Studies of Amphotericin B Methyl Ester and Amphotericin B in Mice, Rats, and Dogs , 1976, Antimicrobial Agents and Chemotherapy.

[13]  P. Hoeprich,et al.  Comparison of amphotericin B and amphotericin B methyl ester: efficacy in murine coccidioidomycosis and toxicity. , 1976, The Journal of infectious diseases.

[14]  R. Tewari,et al.  Comparative Chemotherapeutic Activity of Amphotericin B and Amphotericin B Methyl Ester , 1975, Antimicrobial Agents and Chemotherapy.

[15]  C. Keysser,et al.  Amphotericin B Methyl Ester Hydrochloride and Amphotericin B: Comparative Acute Toxicity , 1973, Science.

[16]  C. Schaffner,et al.  Polyene macrolide derivatives. I. N-acylation and esterification reactions with amphotericin B. , 1972, The Journal of antibiotics.